Safety Of A Sublingual Tablet of House Dust Mite Allergen Extracts In An Environmental Exposure Chamber Study
Poster Mar 09, 2015
Michel Roux, Agnès Viatte, Robert K. Zeldin
Rationale: The efficacy of house dust mite (HDM) sublingual tablets was demonstrated in an environmental exposure chamber (EEC) study of patients with allergic rhinitis upon exposure to HDM allergens. Here we report the safety results.
Methods: Adults (18–55 years) with medically confirmed HDM-associated allergic rhinitis were randomized in this DBPC study to receive 500IR, 300IR or 100IR HDM tablet or placebo daily for 6 months. Patients with intermittent asthma were eligible. Participants were exposed to five 4-hour allergen challenges in the EEC (baseline, treatment months 1, 2, 4, 6). Adverse events (AE) were monitored throughout the study and analyzed descriptively. All patients receiving at least one dose of the investigational product were included in the safety set.
Results: 355 patients (safety set: 500IR=93, 300IR=86, 100IR=89 and Placebo=87) were randomized. 94% (500IR), 91% (300IR), 97% (100IR) and 83% (Placebo) reported at least one AE on treatment. Application site reactions were the most commonly reported AEs (500IR=74%, 300IR=70%, 100IR=69%, and Placebo=37%). The incidence of asthma and related symptoms was higher during the peri-EEC challenge periods (i.e., the day of and the day after challenge; range: 37%-45%) than outside these periods (16%-21%) but was similar across treatment groups. No anaphylaxis or serious drug-related AEs were reported. 20 patients withdrew due to a TEAE, mostly due to application site reactions.
Conclusions: Treatment with HDM sublingual tablets was generally well tolerated regardless of dose. While asthma and related symptoms were more common during the peri-EEC challenge periods, rates did not differ between active and placebo treatment.
Immunotherapy on Chip: “Under the Microscope” Drug-induced Modulation of the Immune ResponsePoster
The immune system is a striking example of an integrated information system, engaged in coordinated host-protective activities. Organs-on-chip approach (OOC) models allow the direct simultaneous observation of hundreds of different cells, moving, interacting and responding to signals coming from the microenvironment nearby, that give access to a number of parameters describing the system that must be properly measured and elaborated.READ MORE
Assessment of Oral LISPRO Treatment in Ameliorating Amyloid and Tau Pathology in Transgenic Alzheimer’s Mice ModelPoster
Ionic co-crystals of lithium salicylate with organic proline (LISPRO) showed better safety and pharmacokinetic profile of lithium in plasma and brain of wild-type and transgenic Alzheimer mice model compared to lithium salts.READ MORE
MHV68 Infection in a Novel rag2 F62L/F62L Mouse Model Based on a Patient with CID-G/AI PhenotypePoster
MHV-68 infection in our rag2 mouse model induced increased antibody responses to virus and self and inflammatory disease in end organs. Major mechanism of inflammatory infiltrates and autoantibody generation is yet to be determinedREAD MORE
Comments | 0 ADD COMMENT
9th International conference on Tissue Engineering and Regenerative Medicine
Nov 09 - Nov 10, 2018